Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kidswell Bio Corporation ( (JP:4584) ) just unveiled an announcement.
Kidswell Bio Corporation reported a significant improvement in its financial performance for the three months ended June 30, 2025, with net sales increasing by 256.3% year-on-year. Despite this growth, the company forecasts a challenging fiscal year ending March 31, 2026, with expected net sales ranging from 5,000 to 5,500 million yen and operating income potentially facing a downturn.
More about Kidswell Bio Corporation
Kidswell Bio Corporation operates in the biotechnology industry, focusing on developing innovative biopharmaceutical products. The company is listed on the Tokyo Stock Exchange and is dedicated to advancing healthcare solutions through its cutting-edge research and development efforts.
Average Trading Volume: 4,594,292
Technical Sentiment Signal: Buy
Current Market Cap: Yen12.7B
Learn more about 4584 stock on TipRanks’ Stock Analysis page.